XYLT2 and neoplasm: Within the EGOT–miR-32-5p–XYLT2 axis identified in our ceRNA network, XYLT2 may contribute to hepatocarcinogenesis by modulating matrix composition and tumor–stromal interactions, warranting further mechanistic investigation (24).